Eureka Laboratory - Breast Marker CA 15-3 test CA 15-3 is not used as a screening or diagnostic test to find breast cancer but may be used to monitor your body's response
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/3-Table2-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer | Bosnian Journal of Basic Medical Sciences Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer | Bosnian Journal of Basic Medical Sciences](https://www.bjbms.org/ojs/public/journals/1/article_3331_cover_en_US.jpg)
Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer | Bosnian Journal of Basic Medical Sciences
![Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4244574818b6181db84800ea19173a80fa71094b/2-TableII-1.png)
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-fx1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.8/MediaObjects/41416_2015_Article_BFbjc20158_Fig1_HTML.jpg)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/4-Table5-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![Electrochemical immunosensor for the breast cancer marker CA 15–3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol | SpringerLink Electrochemical immunosensor for the breast cancer marker CA 15–3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00604-017-2532-5/MediaObjects/604_2017_2532_Figa_HTML.gif)